Cookson R. Effects of NHS reform on socioeconomic equity in health care. Guest Lecture, Wolfson Research Institute, December 2011.
Despiégel N, Danchenko N, François C, Lensberg B, Drummond M. The use and performance of productivity scales to evaluate presenteeism in mood disorders. ISPOR 14th Annual European Congress, Madrid, 5-8 Nov 2011.
Soares MO, NJ Welton, P Peura, DA Harrison, M Shankar Hari, KM Rowan, SJ Palmer. The value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock). ISPOR, 14th annual European congress. Madrid (Nov 2011)
Drummond M. Twenty Years of Using Economic Evaluations for Drug Reimbursement Decisions. What Have We Achieved? 33rd Australian Conference of Health Economists, Melbourne, Sept 2011.
Cost-effectiveness thresholds for decision making about health care technologies: conceptual and empirical underpinnings
Organised session, International Health Economics Association meeting,
Toronto 13 july 2011.
Drummond M. Economic Analysis in NICE Clinical Guidelines in the United Kingdom. International Health Economics Association (iHEA), Toronto, July 2011.
Cookson R. Effects of choice and market reform on socioeconomic inequalities of access to health care, SDO Network CEO Forum, Nottingham, June 2011.
Cookson R. Effects of health reform on health care inequality. HSRN/SDO Annual Conference, Liverpool, June 2011.
Walker S. Value for money and the Quality and Outcomes Framework in primary care in the NHS- Health Sciences Group Primary Care Seminar, University of Manchester June 2011
Cookson R. Happiness and capability approaches, NICE Annual Conference, 10-11 May 2011, Birmingham.
Drummond M. Restricting Access to Healthcare: Is NICE Too Nasty? Presentation to the Public Health Economics Group, John Hopkins University, Baltimore, May 2011.
Soares MO, Bojke L, Dumville JC, Iglesias C, Cullum N, Claxton K. Using elicitation to quantify experts’ beliefs regarding the use of negative pressure wound therapy for severe pressure ulceration. The 2011 International Nursing Research Conference - Royal College of Nursing of the United Kingdom (Apr 2011).
Soares MO, McKenna C, Spackman E, Bojke L, Griffin S, Palmer S, Claxton K. Unifying research and reimbursement decisions: examining two case studies. Economic Evaluation and Health Technology Assessment Seminar Series (Feb 2011)
Soares MO, Dumville JC, Iglesias C, Bojke L, Cullum N, Claxton K, Methods to assess cost effectiveness and value of further research when data are sparse: negative pressure wound therapy for severe pressure ulcers. Health Economists' Study Group meeting, York. (Jan 2011)
Spackman E, Griffin S, Fleurence R, Kim E. "Model Busting": Methods and experience in the critical appraisal of cost-effectiveness models submitted to reimbursement agencies. ISPOR Madrid 2011. Workshop.
Spackman E, Fleurence R, Kim E, Naci H. Moving towards value based health care in different constituencies, A presentation on behalf of the ISPOR value based health care special interest group. ISPOR Madrid 2011. Workshop.
Spackman E. The health economics of preventive medicine: Is an ounce of screening worth a pound (1.15 euro)? EUFEP Krems Austria, 2011. Invited Talk.
Claxton K, Spackman E, Griffin S, Palmer S, Longworth L, Bojke L, Youn, J. Unifying research and reimbursement decisions: a framework and algorithm for policy choice. HESG 2011.
Longworth L, Youn J, Bojke L, Palmer S, Griffin S, Spackman E, Claxton K. When does NICE issue ‘Approval with Evidence’ recommendations? A review of ‘Only In Research’ and ‘Approval With Research’ recommendations in NICE guidance. HESG 2011.
Hinde S, Spackman E, Claxton K, Sculpher M. The cost-effectiveness threshold: The results of a novel literature review method. ISPOR Madrid, Spain 2011. Poster.
Sullivan SD, Bloudek L, Spackman DE, Blankenburg M. A Meta-analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease. ISPOR Baltimore, 2011.